Skip to main content
Clinical Trials/NCT02817048
NCT02817048UnknownNot Applicable

Thoracoscopic Surgery Without Chest Tube Placement in Patients With Peripheral Lung Nodules: A Prospective Randomized Trial

National Taiwan University Hospital0 sites100 target enrollmentStarted: June 1, 2016Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
100
Primary Endpoint
Postoperative hospital stay

Study Overview

Brief Summary

Chest tube placement after thoracoscopy surgery had been generally accepted as routine procedure for removal of the residual intrapleural fluid and air, however, it would cause post-operative pain, prohibit ambulation after surgery, and prolong the hospital stay. According to the recent studies, omission of chest tube placement after minor thoracoscopic procedures (such as pulmonary wedge resection) had been safe and feasible, and it also reduced the post-operative pain and shortened the hospital stay. We will conduct a prospective randomized trial in National Taiwan University Hospital.

Detailed Description

We will enroll 100 patients with peripheral lung nodule who will be randomly assigned to no chest tube placement (tubeless group) or chest tube placement (control group) after thoracoscopic wedge resection with out without lymph adenectomy. The primary endpoints are to compare the post-operative hospital stay and post-operative pain sale between the two groups. The secondary endpoints are to compare the intercostal neuralgia and wound satisfaction one month after surgery between the two groups.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
20 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •CT revealed peripheral lung nodule, with both size and depth less than 2 cm
  • •Aged 20 to 80 years

Exclusion Criteria

  • •Patients with ventilatory defect
  • •Previous ipsilateral thoracic surgery
  • •Bleeding tendency or anticoagulant use
  • •Comorbidity including congestive heart failure, liver cirrhosis, chronic renal disease
  • •Pregnancy or breast feeding
  • •Immunocompromised or long-term steroid use
  • •Severe infected patient
  • •Patient who can not sign permit

Arms & Interventions

Chest tube

Active Comparator

VATS with chest tube placement

Intervention: chest tube (Device)

Chest tube

Active Comparator

VATS with chest tube placement

Intervention: VATS with chest tube placement (Procedure)

Tubeless

Active Comparator

Interventions: VATS without chest tube placement

Intervention: VATS without chest tube placement (Procedure)

Outcomes

Primary Outcomes

Postoperative hospital stay

Time Frame: 1 week

Secondary Outcomes

  • Postoperative pain score(1 week)
  • Postoperative intercostal neuralgia(1 month)
  • Postoperative wound satisfaction(1 month)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials